If India doesn't release anti-malaria drug, there will be retaliation, says Trump US President Donald Trump has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States despite a request made to New Delhi over the subject.
US President Donald Trump has said that if India does not allow export of anti-malaria drug Hydroxychloroquine to the US, as requested, there may be retaliation.
Last week Trump said that he has sought help from Prime Minister Narendra Modi to allow the sale of Hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country, hours after India banned the export of the anti-malarial drug.
He has said he would be surprised if India did not allow the export of Hydroxychloroquine tablets to the United States.
"So, I would be surprised if that were his decision. He'd have to tell me that. I spoke to him Sunday morning, called him, and I said we'd appreciate your allowing our supply to come out. If he doesn't allow it to come out, that would be okay, but of course, there may be retaliation. Why wouldn't there be?" Trump said.
"I would be surprised if he would, you know, because India does very well with the United States," Trump told reporters during a press briefing at the White House on Monday.
Hydroxychloroquine tablet is used to prevent and treat malaria, lupus and rheumatoid arthritis, among other ailments.
The drug is seen as to offer a viable therapeutic solution to coronavirus that has so far taken the lives of more than 10,000 Americans and infected over 3.6 lakhs, just in a matter of weeks.
Last month, India imposed a ban on export on Hydroxychloroquine, on which Trump is now banking heavily in the treatment of Covid-19 patients.
India has received similar requests from several other countries including its immediate neighbors like Sri Lanka and Nepal. India has said that it is reviewing its export ban order.
Notably, India's decision to ban the exports of Hydroxychloroquine is driven by its desire to take stock of the domestic requirements and ensure that the country has enough in its kitty.
Reiterating that for many years, India has been taking advantage of the US on trade, Trump said that he would be surprised if New Delhi was to stop export of Hydroxychloroquine to the US.
On Monday, a senior State Department official said that India has been a significant partner of the US in the pharmaceutical sector and it expects similar cooperation to continue between the economies.
"India has long been a significant partner of the United States and the pharmaceutical sector," Alice G Wells, the Acting Assistant Secretary of State for South and Central Asia, told reporters during a press briefing.
The Trump administration has already created a national strategic stockpile of 29 million doses of the malaria drug, anticipating that its test results on more than 1,500 Covid-19 patients in New York is yielding positive results.
Scientists have begun testing Hydroxychloroquine and chloroquine as candidates for potential COVID-19 treatments and the FDA last week issued an Emergency Use Authorization for the prescription of the drugs in certain circumstances.
In addition to New York, Covid-19 patients in several States are being treated with Hydroxychloroquine, including Michigan and Texas.
அமெரிக்காவுக்கு hydroxychloroquine மருந்தை ஏற்றுமதி செய்ய இந்தியா அனுமதி அளிக்காவிட்டால், அதற்கு தகுந்த பதிலடி அளிக்கப்படும் என அதிபர் டிரம்ப் தெரிவித்துள்ளது கடும் சர்ச்சையை ஏற்படுத்தியுள்ளது.
உலக அளவில் இதுவரை இல்லாத அளவுக்கு கடந்த 24 மணி நேரத்தில் அமெரிக்காவில் மட்டும் 1150 பேர் கொரோனாவால் பலியாகியுள்ளது கடும் அதிர்ச்சியை ஏற்படுத்தியுள்ளது.
Stealing masks and stockpiling hydroxychloroquine — what America has become during this epidemic is deeply worrying.
Under Trump's crisis leadership, the US has been accused of modern piracy on the airport tarmac, considered denying medical supplies to Canada and taken medication off lupus patients. Meanwhile, New York has to take donations off China.
Last night, in the most recent of several long and strange press conferences, President Trump announced that the United States had amassed 29 million pills of hydroxychloroquine, a yet-unproven treatment that may assist in improving outcomes with Covid-19. Shortly after Trump spoke, Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, was prevented from answering any questions pursuant to the drug and its uses.
The reason that Fauci was not permitted to speak at that presser was because there is still much debate about whether or not this drug can even be used to treat Covid-19 — and a whole other host of ethical considerations about removing from circulation a drug that is already useful in treating lupus, since now those patients will no longer have access to it. Unlike what Trump claimed, the FDA has not actually approved hydroxychloroquine as a coronavirus treatment. Fauci has already made clear his reluctance to kowtow to the president, as many other administration sycophants have done in the past, and was likely to have mentioned that if he’d been allowed to speak. But Trump hates a dissident, so Fauci was forced into silence.
The stockpiling of hydroxychloroquine presents a darker truth about the American methodology in the era of Covid-19, however. We shouldn’t just be concerned about the way President Trump is personally conducting himself. Seen as part of a whole, what Americans have committed — and are continuing to commit — is, essentially, modern piracy.
On April 2, it was reported that “US buyers waving wads of cash managed to wrest control of a consignment of masks as it was about to be dispatched from China to one of the worst-hit coronavirus areas of France”. On April 3, a second story hit the press, claiming that 200,000 N95 masks, destined for Germany from China, were diverted to the United States during a plane transfer in Thailand. The masks had been ordered for the Berlin police force. As of today, Germany has over 100,000 coronavirus cases, the fourth-most in the world, behind Italy, Spain, and the United States.
The hydroxychloroquine stockpiling, then, is not an act in a vacuum. Instead, it’s an example of ongoing behavior that’s wholly indicative of what the United States has become under the ethically vacuous leadership of President Trump. It seems that Americans don’t care if others suffer while they engage in piracy to the express benefit of their people (so long as they don’t have lupus, in which case they’ll be denied medication and thanked for their sacrifice) — and the detriment of the rest of the world. Indeed, at some points it even seems to have descended into a state vs. state brawl, with Trump accused of pandering to red states and refusing ventilators to New York, which is in desperate need (over the weekend, China donated 1,000 ventilators to the state when the federal government couldn’t assure governors they would be able to deliver enough medical supplies.)
But if coronavirus presents any lesson inherent, it’s that borders and boundaries are useless in a global economy. If one state or country or leader fails, we all do, which is why hoarding supplies, or stealing from each other, or engaging in subterfuge has no long-term use beyond tanking everything. The greed of piracy fails to see the broad picture of how a world depends on the health, safety, and welfare of all of its residents, rich and poor, American, British, French, German, and every other nationality in between. Asking American companies not to provide medical supplies to Canada or South America will have a direct impact on people inside the US. That’s a fact that President Trump has never grasped, and likely never will.
Even if hydroxychloroquine proves to be a miracle drug that saves millions of lives (and, to be clear, no doctor, including Dr Fauci, has confirmed that this hopeful prognosis is anything but a hypothesis as of right now), providing the drug to only Americans serves no real purpose, just like stealing masks from the French or from the Berlin police force serves no real purpose. Infections don’t check your national identity before proliferating. But, of course, telling Trump to wait his turn serves about as much purpose as telling a tantrum-throwing one-year-old to wait his turn. A leader with no vision for the future will never truly be able to lead. So what can we really, earnestly expect?
Here we are, at the threshold. The only hope remaining is that the few mitigating forces that surround the president can rein him in and remind him that the United States is not autonomous in the world, but that this country is, rather, a cog. If we have any hope in surviving the decimation of death and destruction that we now face — miracle drug or not — we must hope for the improved health and welfare of every single person on this planet. Without that, there is nothing.
Hey ravanan, there was too many links in the content, i have to re edit it to avoid links in the content. Next time when you copy paste, make sure you paste the content in notepad and then do it in here from notepad. In this way the html tags and hyperlinks will be avoided in default.
Foreign correspondent covering India
Education: Delhi University, BA in English; Columbia Graduate School of Journalism, MA in JournalismNiha Masih is An India-based correspondent for The Washington Post based in New Delhi. Before joining The Post in 2019, she reported on politics, conflict and religious...
Washington Dc Advising America To Follow Kerala Model For Fight Against Corona
NEW DELHI — For hours, the health worker ticked through a list of questions: How is your health? What is your state of mind? Are you running out of any food supplies? By the end of the afternoon, she had reached more than 50 people under coronavirus quarantine. Weeks earlier, that number was 200.
The measures appear to be paying off. Even though Kerala was the first state to report a coronavirus case in late January, the number of new cases in the first week of April dropped 30 percent from the previous week. With just two deaths, 34 percent of positive patients have recovered in the state, higher than elsewhere in India.
The success in Kerala could prove instructive for The Indian government, which has largely shut down the country to stop the spread of the contagion but continues to see the curve trend upward, with more than 6,700 confirmed cases and more than 200 deaths. Its challenges are plenty — from high population density to poor health care facilities — but experts say Kerala’s proactive measures like early detection and broad social support measures could serve as a model for the rest of the country.
“We hoped for the best but planned for the worst,” said K.K. Shailaja, the state’s health minister, while cautioning that the pandemic is not yet over in Kerala. “Now, the curve has flattened, but we cannot predict what will happen next week.”
Kerala’s approach was effective because it was “both strict and humane,” said Shahid Jameel, a virologist, and infectious disease expert.
“Aggressive testing, isolating, tracing and treating — those are ways of containing an outbreak,” said Jameel, who is also the CEO of the Wellcome Trust/DBT India Alliance, a foundation with offices in Hyderabad and New Delhi.
Henk Bekedam, the World Health Organization’s representative in India attributed Kerala’s “prompt response” to its past “experience and investment” in emergency preparedness and pointed to measures such as district monitoring, risk communication, and community engagement.
The state faced a potentially disastrous challenge: a disproportionately high number of foreign arrivals. Popular for its tranquil backwaters and health retreats, the coastal state receives more than 1 million foreign tourists a year. One-sixth of its 33 million citizens are expatriates, and hundreds of its students study in China.
Screening at airports was tightened, and travelers from nine countries — including coronavirus hotspots such as Iran and South Korea — were required to quarantine at home starting on Feb. 10, two weeks before India put similar restrictions into place. In one instance, more than a dozen foreign nationals were removed from a flight before takeoff because they had not completed their isolation period. Temporary quarantine shelters were established to accommodate tourists and other nonresidents.
Still, some slipped through. The arrival of a local couple from Italy in the last week of February who did not report to health officials caused an alarm. By the time they were detected, the couple had attended several social gatherings and traveled widely. Nearly 900 primary and secondary contacts were traced and isolated.
Robin Thomas, 34, the son-in-law of the couple who returned from Italy, tested positive for coronavirus, as did his wife and his wife’s grandparents. He said apart from the “excellent treatment” he received, the medical staff also helped them overcome stigma.
“People were blaming us on Facebook and WhatsApp,” he said. “The counselors called us over the phone regularly and gave us confidence.
Shailaja, the health minister, said six states had reached out to Kerala for advice. But it may not be easy to replicate Kerala’s lessons elsewhere in India.
The state, where communists have held power for more than 30 years in a series of different governments since the 1950s, has invested heavily in public education and universal health care. Kerala has the highest literacy rate and benefits from the best-performing public health system in the country. It tops India’s rankings on neonatal mortality, birth immunizations and the availability of specialists at primary care facilities.
The strength of its health care system allowed it to follow the World Health Organization’s recommendation on aggressive testing, even as central agencies maintained that mass testing was not feasible in a country like India. Through the first week of April, Kerala had conducted more than 13,000 tests, accounting for 10 percent of all tests done across India. By comparison, Andhra Pradesh, a larger state with a similar number of cases, had carried out nearly 6,000 tests while Tamil Nadu, with more than double, the number of cases had done more than 8,000 tests.
The state took the lead in deploying rapid testing kits, which officials say they continue to use in hotspots to check community spread. This week, Kerala began walk-in testing facilities, which reduce the need for protective gears for health workers.
Kerala also announced an economic package worth $2.6 billion to fight the pandemic days before the central government instituted a harsh lockdown that left many states scrambling. It delivered uncooked lunches to schoolchildren, liaised with service providers to increase network capacity for Internet at homes and promised two months of advance pension.
But there have also been some blips. The state was criticized for going ahead with a local festival in early March that drew thousands of people. Amar Fettle, the state officer responsible for health emergencies, said there was still room for improvement on aspects like social distancing in markets, cough hygiene, and lockdown implementation.
Thomas and his wife have recovered, as has his wife’s elderly grandparents — 88 and 93 — who were discharged this week.
“We were very worried about them and though they may not survive,” Thomas said. “Even when grandfather had a heart attack, the doctors told us they will keep trying.”
Shahina K.K. contributed reporting from Kochi, Kerala. Correction:An earlier version of this article included an incorrect title for Shahid Jameel. He is CEO of the Wellcome Trust/DBT India Alliance. This version has also been updated to clarify that communist parties in Kerala have alternated with other parties in power.
Source: The Washington Post,
The United States of America.